Literature DB >> 11784388

Topiramate in drug-resistant complex partial status epilepticus.

M Reuber, J Evans, J M Bamford.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11784388     DOI: 10.1046/j.1468-1331.2002.00304.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


× No keyword cloud information.
  7 in total

Review 1.  Antiseizure medications in critical care: an update.

Authors:  Baxter Allen; Paul M Vespa
Journal:  Curr Opin Crit Care       Date:  2019-04       Impact factor: 3.687

2.  Topiramate as an adjunctive treatment in patients with refractory status epilepticus: an observational cohort study.

Authors:  Annalena Hottinger; Raoul Sutter; Stephan Marsch; Stephan Rüegg
Journal:  CNS Drugs       Date:  2012-09-01       Impact factor: 5.749

Review 3.  Management of seizures in critically ill patients.

Authors:  Panayiotis N Varelas; Marek A Mirski
Journal:  Curr Neurol Neurosci Rep       Date:  2004-11       Impact factor: 5.081

Review 4.  [Refractory status epilepticus: diagnosis, therapy, course, and prognosis].

Authors:  F Bösebeck; G Möddel; K Anneken; M Fischera; S Evers; E B Ringelstein; C Kellinghaus
Journal:  Nervenarzt       Date:  2006-10       Impact factor: 1.214

5.  Enteral topiramate in a pediatric patient with refractory status epilepticus: a case report and review of the literature.

Authors:  Chasity M Shelton; Elizabeth L Alford; Stephanie Storgion; James Wheless; Stephanie J Phelps
Journal:  J Pediatr Pharmacol Ther       Date:  2014 Oct-Dec

Review 6.  Systematic review of clobazam use in patients with status epilepticus.

Authors:  Sherif Hanafy Mahmoud; Caleb Rans
Journal:  Epilepsia Open       Date:  2018-06-13

7.  Effectiveness of topiramate in medically complicated patients with status epilepticus or acute refractory seizures.

Authors:  Woojun Kim; Se Yoon Kwon; A Hyun Cho; Sung Chul Lim; Yeong In Kim; Young-Min Shon
Journal:  J Epilepsy Res       Date:  2011-12-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.